Taken together, our analysis of chromatin accessibility across a multitude of AML patient samples and healthy hematopoietic cell types showed that NUP98 fusion-driven AML harbors an epigenetic signature that is characterized by increased accessibility of HSC-associated regions and enrichment of activating histone marks. The gene discussed is NUP98; the disease is acute myeloid leukemia.